143 related articles for article (PubMed ID: 22323863)
1. Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy.
Kim JY; Ghee JY; Lim SW; Piao SG; Chung BH; Yoon HE; Hwang HS; Choi BS; Kim J; Yang CW
J Korean Med Sci; 2012 Feb; 27(2):160-9. PubMed ID: 22323863
[TBL] [Abstract][Full Text] [Related]
2. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
[TBL] [Abstract][Full Text] [Related]
3. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
4. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
5. Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers.
Sereno J; Nunes S; Rodrigues-Santos P; Vala H; Rocha-Pereira P; Fernandes J; Santos-Silva A; Teixeira F; Reis F
Biomed Res Int; 2014; 2014():576929. PubMed ID: 24971338
[TBL] [Abstract][Full Text] [Related]
6. Influence of sirolimus on cyclosporine-induced pancreas islet dysfunction in rats.
Song HK; Han DH; Song JH; Ghee JY; Piao SG; Kim SH; Yoon HE; Li C; Kim J; Yang CW
Am J Transplant; 2009 Sep; 9(9):2024-33. PubMed ID: 19624561
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat.
Sereno J; Vala H; Nunes S; Rocha-Pereira P; Carvalho E; Alves R; Teixeira F; Reis F
J Physiol Pharmacol; 2015 Apr; 66(2):285-99. PubMed ID: 25903959
[TBL] [Abstract][Full Text] [Related]
9. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus.
Sereno J; Parada B; Rodrigues-Santos P; Lopes PC; Carvalho E; Vala H; Teixeira-Lemos E; Alves R; Figueiredo A; Mota A; Teixeira F; Reis F
Transplant Proc; 2013 Apr; 45(3):1149-56. PubMed ID: 23622648
[TBL] [Abstract][Full Text] [Related]
10. Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity.
Fernandes I; Zhang Y; Qi Y; Wang ME; Podder H; Lisik W; Knight R; Kahan BD; Stepkowski SM
Transplantation; 2009 Dec; 88(12):1323-31. PubMed ID: 20029328
[TBL] [Abstract][Full Text] [Related]
11. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
[TBL] [Abstract][Full Text] [Related]
12. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
13. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
[TBL] [Abstract][Full Text] [Related]
14. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
15. Preclinical results of sirolimus treatment in transplant models.
Stepkowski SM
Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
Johnson RW; Kreis H; Oberbauer R; Brattström C; Claesson K; Eris J
Transplantation; 2001 Sep; 72(5):777-86. PubMed ID: 11571437
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Andoh TF
Am J Nephrol; 2006; 26(4):400-7. PubMed ID: 16926534
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
Martin-Martin N; Ryan G; McMorrow T; Ryan MP
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
